Focal Cerebral Ischemia and Reperfusion Induce Brain Injury Through α2δ-1–Bound NMDA Receptors. Issue 10 (October 2018)
- Record Type:
- Journal Article
- Title:
- Focal Cerebral Ischemia and Reperfusion Induce Brain Injury Through α2δ-1–Bound NMDA Receptors. Issue 10 (October 2018)
- Main Title:
- Focal Cerebral Ischemia and Reperfusion Induce Brain Injury Through α2δ-1–Bound NMDA Receptors
- Authors:
- Luo, Yi
Ma, Huijie
Zhou, Jing-Jing
Li, Lingyong
Chen, Shao-Rui
Zhang, Jixiang
Chen, Lin
Pan, Hui-Lin - Abstract:
- Abstract : Background and Purpose—: Glutamate NMDARs (N-methyl-D-aspartate receptors) play a major role in the initiation of ischemic brain damage. However, NMDAR antagonists have no protective effects in stroke patients, possibly because they impair physiological functions of NMDARs. α2δ-1 (encoded by Cacna2d1 ) is strongly expressed in many brain regions. We determined the contribution of α2δ-1 to NMDAR hyperactivity and brain injury induced by ischemia and reperfusion. Methods—: Mice were subjected to 90 minutes of middle cerebral artery occlusion followed by 24 hours of reperfusion. Neurological deficits, brain infarct volumes, and calpain/caspase-3 activity in brain tissues were measured. NMDAR activity of hippocampal CA1 neurons was measured in an in vitro ischemic model. Results—: Middle cerebral artery occlusion increased α2δ-1 protein glycosylation in the cerebral cortex, hippocampus, and striatum. Coimmunoprecipitation showed that ischemia rapidly enhanced the α2δ-1–NMDAR physical interaction in the mouse brain tissue. Inhibiting α2δ-1 with gabapentin, uncoupling the α2δ-1–NMDAR interaction with an α2δ-1 C terminus–interfering peptide, or genetically ablating Cacna2d1 had no effect on basal NMDAR currents but strikingly abolished oxygen-glucose deprivation–induced NMDAR hyperactivity in hippocampal CA1 neurons. Systemic treatment with gabapentin or α2δ-1 C-terminus–interfering peptide or Cacna2d1 genetic knock-out reduced middle cerebral artery occlusion–inducedAbstract : Background and Purpose—: Glutamate NMDARs (N-methyl-D-aspartate receptors) play a major role in the initiation of ischemic brain damage. However, NMDAR antagonists have no protective effects in stroke patients, possibly because they impair physiological functions of NMDARs. α2δ-1 (encoded by Cacna2d1 ) is strongly expressed in many brain regions. We determined the contribution of α2δ-1 to NMDAR hyperactivity and brain injury induced by ischemia and reperfusion. Methods—: Mice were subjected to 90 minutes of middle cerebral artery occlusion followed by 24 hours of reperfusion. Neurological deficits, brain infarct volumes, and calpain/caspase-3 activity in brain tissues were measured. NMDAR activity of hippocampal CA1 neurons was measured in an in vitro ischemic model. Results—: Middle cerebral artery occlusion increased α2δ-1 protein glycosylation in the cerebral cortex, hippocampus, and striatum. Coimmunoprecipitation showed that ischemia rapidly enhanced the α2δ-1–NMDAR physical interaction in the mouse brain tissue. Inhibiting α2δ-1 with gabapentin, uncoupling the α2δ-1–NMDAR interaction with an α2δ-1 C terminus–interfering peptide, or genetically ablating Cacna2d1 had no effect on basal NMDAR currents but strikingly abolished oxygen-glucose deprivation–induced NMDAR hyperactivity in hippocampal CA1 neurons. Systemic treatment with gabapentin or α2δ-1 C-terminus–interfering peptide or Cacna2d1 genetic knock-out reduced middle cerebral artery occlusion–induced infarct volumes, neurological deficit scores, and calpain/caspase-3 activation in brain tissues. Conclusions—: α2δ-1 is essential for brain ischemia–induced neuronal NMDAR hyperactivity, and α2δ-1–bound NMDARs mediate brain damage caused by cerebral ischemia. Targeting α2δ-1–bound NMDARs, without impairing physiological α2δ-1–free NMDARs, may be a promising strategy for treating ischemic stroke. Abstract : Supplemental Digital Content is available in the text. … (more)
- Is Part Of:
- Stroke. Volume 49:Issue 10(2018)
- Journal:
- Stroke
- Issue:
- Volume 49:Issue 10(2018)
- Issue Display:
- Volume 49, Issue 10 (2018)
- Year:
- 2018
- Volume:
- 49
- Issue:
- 10
- Issue Sort Value:
- 2018-0049-0010-0000
- Page Start:
- Page End:
- Publication Date:
- 2018-10
- Subjects:
- brain -- ischemia -- caspase -- 3 -- gabapentin -- hippocampus -- neurons -- NMDA receptor -- pregabalin
Cerebrovascular disease -- Periodicals
Cerebral circulation -- Periodicals
616.81 - Journal URLs:
- http://ovidsp.tx.ovid.com/sp-3.16.0b/ovidweb.cgi?&S=GJCMFPNHCPDDNANKNCKKCFFBNGMHAA00&Browse=Toc+Children%7cYES%7cS.sh.15204_1441956414_76.15204_1441956414_88.15204_1441956414_96%7c411%7c50 ↗
http://www.stroke.ahajournals.org/ ↗
http://stroke.ahajournals.org/ ↗
http://journals.lww.com ↗
http://www.lww.com/Product/0039-2499 ↗ - DOI:
- 10.1161/STROKEAHA.118.022330 ↗
- Languages:
- English
- ISSNs:
- 0039-2499
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 8474.900000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 10897.xml